Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 11 Issue: 7, July

Editorial [Hot topic: New and Emerging Drug Targets for the Treatment of Hematological Malignancies (Guest Editors: Dr. Linda J. Bendall)]

Volume:11   Issue: 7
Pp: 767-768
Linda J. Bendall
DOI: 10.2174/138945010791320890
Published on: 01 March, 2012

Cell Death Targeting Therapies in B Lymphoid Malignancies

Volume:11   Issue: 7
Pp: 769-780
I. Saborit-Villarroya, G. Roue, M. Lopez-Guerra, R. Alonso, S. Xargay-Torrent, L. Rosich and D. Colomer
DOI: 10.2174/138945010791320863
Published on: 01 March, 2012

Bench to Bedside Targeting of FLT3 in Acute Leukemia

Volume:11   Issue: 7
Pp: 781-789
Keith W. Pratz and Mark J. Levis
DOI: 10.2174/138945010791320782
Published on: 01 March, 2012

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

Volume:11   Issue: 7
Pp: 790-800
Aude-Helene Capietto, Samarh Keirallah, Emilie Gross, Nicolas Dauguet, Emilie Laprevotte, Christine Jean, Julie Gertner-Dardenne, Christine Bezombes, Anne Quillet-Mary, Mary Poupot, Loic Ysebaert, Guy Laurent and Jean-Jacques Fournie
DOI: 10.2174/138945010791320845
Published on: 01 March, 2012

MicroRNAs in Leukemias: Emerging Diagnostic Tools and Therapeutic Targets

Volume:11   Issue: 7
Pp: 801-811
Yousaf A. Mian and Nancy J. Zeleznik-Le
DOI: 10.2174/138945010791320872
Published on: 01 March, 2012

Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma

Volume:11   Issue: 7
Pp: 812-822
David M. Lucas, Patrick C. Still, Lynette Bueno Perez, Michael R. Grever and A. Douglas Kinghorn
DOI: 10.2174/138945010791320809
Published on: 01 March, 2012

The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies

Volume:11   Issue: 7
Pp: 823-833
Shivashni S. Gaundar and Linda J. Bendall
DOI: 10.2174/138945010791320854
Published on: 01 March, 2012

Molecular Targeted Therapy of Biliary Tract Cancer – Results of the First Clinical Studies

Volume:11   Issue: 7
Pp: 834-850
Marcus W. Wiedmann and Joachim Mossner
DOI: 10.2174/138945010791320818
Published on: 01 March, 2012

Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy

Volume:11   Issue: 7
Pp: 865-874
Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Rita Ambrosio, Marzia Falanga and Cesare Gridelli
DOI: 10.2174/138945010791320791
Published on: 01 March, 2012

Smooth Muscle Cell Pathophysiology and Advanced Glycation End Products (AGEs)

Volume:11   Issue: 7
Pp: 875-881
Sho-ichi Yamagishi and Takanori Matsui
DOI: 10.2174/138945010791320827
Published on: 01 March, 2012

Leukotrienes and Atherosclerosis

Volume:11   Issue: 7
Pp: 882-887
Graziano Riccioni, Magnus Back and Valerie Capra
DOI: 10.2174/138945010791320881
Published on: 01 March, 2012

Stem Cell Based Therapy in the Inner Ear: Appropriate Donor Cell Types and Routes for Transplantation

Volume:11   Issue: 7
Pp: 888-897
Nopporn Jongkamonwiwat, Azel Zine and Marcelo N. Rivolta
DOI: 10.2174/138945010791320836
Published on: 01 March, 2012